Skip to main content
. 2023 Jun 14;18(6):e0286303. doi: 10.1371/journal.pone.0286303

Fig 6. Proportion of CALHIV currently on ART, on optimized pediatric regimens, and virally suppressed at 36 SIDHAS-supported sites, by age group and quarter (October 2019–March 2021).

Fig 6